Home
Kynam Capital Management reported a 2.23% stake in enGene Therapeutics ENGN · 1,492,898 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.23%
- Last report
- 9.8% · filed 25/02/14
- Shares held
- 1,492,898 sh
- Class
- Common Shares, no par value per share
- Holder
- Kynam Capital Management
- Event date
- 25/12/31
- Filed
- 26/02/17
2.23% stake · below 5%
- Stake
- 2.23%
- Last report
- 9.8%
- Since last report
- −7.6pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Kynam Capital Management's other 5% stake reports
- Kynam Capital Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5.7% stake
0 sh
5.7% stake
Filed 08/14
- Kynam Capital Management
5% stakeVera Therapeutics
5% stakeVera Therapeutics
VERA
4.01% stake
0 sh
4.01% stake
Filed 08/14
- Kynam Capital Management
5% stakeCytomX Therapeutics
5% stakeCytomX Therapeutics
CTMX
9.96% stake
0 sh
9.96% stake
Filed 08/14
- Kynam Capital Management
5% stakeCelldex Therapeutics
5% stakeCelldex Therapeutics
CLDX
6.78% stake
0 sh
6.78% stake
Filed 08/14
- Kynam Capital Management
5% stakeBurning Rock Biotech
5% stakeBurning Rock Biotech
BNR
13.97% stake
0 sh
13.97% stake
Filed 05/15
